Clinical Trials Browser

OTHER × Recurrence × tivozanib × Clear all

NCT01853644 2021-10-12

TIVO

Phase 2 Completed

31 enrolled 12 charts

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Neoplasms, Recurrence